SKAN Group AG

Swiss Stock Exchange SKAN.SW

SKAN Group AG EBITDA Margin for the year ending December 31, 2023: 15.67%

SKAN Group AG EBITDA Margin is 15.67% for the year ending December 31, 2023, a 8.08% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

SKAN Group AG EBITDA Margin for the year ending December 31, 2022 was 14.50%, a 4.88% change year over year.
SKAN Group AG EBITDA Margin for the year ending December 31, 2021 was 13.82%, a 60.76% change year over year.
SKAN Group AG EBITDA Margin for the year ending December 31, 2020 was 8.60%, a -98.22% change year over year.
SKAN Group AG EBITDA Margin for the year ending December 31, 2019 was 482.37%, a 126.57% change year over year.

Key data

Date	EBITDA Margin	EBIT Margin	Depreciation and Amortization	EBIT

Swiss Stock Exchange: SKAN.SW

SKAN Group AG

CEO	Mr. Thomas Huber
IPO Date	Dec. 28, 2021
Location	Switzerland
Headquarters	Kreuzstrasse 5
Employees	1,419
Sector	Health Care
Industries Pharmaceuticals Chemicals & Advanced Materials

Description

SKAN Group AG provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Asia, Europe, the Americas, and internationally. It operates in two segments: Equipment and Solutions (E&S) and Services and Consumables (S&C). The E&S segment offers mission-critical solutions for the pharmaceutical production, including isolators, integrated automated systems, and aseptic filling systems and solutions, as well as laboratory and cleanroom equipment. The S&C segment provides life cycle support and ready-to-use consumables, as well as customer- specific and digital solutions. The company was formerly known as BV Holding AG and changed its name to SKAN Group AG in October 2021. SKAN Group AG was founded in 1968 and is headquartered in Allschwil, Switzerland.

Key trends

Past 5 years